Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Times Interest Earned (2016 - 2025)

vTv Therapeutics' Times Interest Earned history spans 11 years, with the latest figure at -$7885.0 for Q4 2025.

  • For Q4 2025, Times Interest Earned changed N/A year-over-year to -$7885.0; the TTM value through Dec 2025 reached -$32808.0, changed N/A, while the annual FY2025 figure was -$5468.0, N/A changed from the prior year.
  • Times Interest Earned for Q4 2025 was -$7885.0 at vTv Therapeutics, down from -$672.43 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$267.17 in Q3 2021 and bottomed at -$7885.0 in Q4 2025.
  • The 4-year median for Times Interest Earned is -$1342.0 (2023), against an average of -$2696.4.
  • The largest annual shift saw Times Interest Earned crashed 6878.72% in 2021 before it skyrocketed 42.9% in 2022.
  • A 4-year view of Times Interest Earned shows it stood at -$1851.5 in 2021, then surged by 42.9% to -$1057.2 in 2022, then soared by 36.39% to -$672.43 in 2023, then tumbled by 1072.62% to -$7885.0 in 2025.
  • Per Business Quant, the three most recent readings for VTVT's Times Interest Earned are -$7885.0 (Q4 2025), -$672.43 (Q4 2023), and -$1342.0 (Q3 2023).